REPORTS

Let’s Pullulate and Expand Your Business

Global Flu Vaccine (Influenza Vaccine) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020  |  168 PAGES  |  REPORT CODE: CMM332581
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.

The Flu Vaccine (Influenza Vaccine) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The research provides insights for the global Flu Vaccine (Influenza Vaccine) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Flu Vaccine (Influenza Vaccine) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Flu Vaccine (Influenza Vaccine) Market Segmentations:

By Players:

  • CSL

  • GSK

  • Sanofi Pasteur

  • Mylan

  • AstraZeneca

  • Pfizer

  • Johnson & Johnson

By Types:

  • Whole Virus Vaccines

  • Split Virus Vaccines

  • Subunit Vaccines

  • Live Attenuated Virus Vaccines

By End-User:

  • For Children (6 months to 3 years)

  • For Adults and Children over 3 years

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Flu Vaccine (Influenza Vaccine) Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines from 2014 to 2026

    • 1.3.2 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines from 2014 to 2026

    • 1.3.3 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines from 2014 to 2026

    • 1.3.4 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Children (6 months to 3 years) from 2014 to 2026

    • 1.4.2 Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Adults and Children over 3 years from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Flu Vaccine (Influenza Vaccine) Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Flu Vaccine (Influenza Vaccine) by Major Types

    • 3.4.1 Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines

    • 3.4.2 Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines

    • 3.4.3 Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines

    • 3.4.4 Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines

4 Segmentation of Flu Vaccine (Influenza Vaccine) Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Flu Vaccine (Influenza Vaccine) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Flu Vaccine (Influenza Vaccine) in For Children (6 months to 3 years)

    • 4.4.2 Market Size and Growth Rate of Flu Vaccine (Influenza Vaccine) in For Adults and Children over 3 years

5 Market Analysis by Major Regions

  • 5.1 Global Flu Vaccine (Influenza Vaccine) Production Analysis by Major Regions

  • 5.2 Global Flu Vaccine (Influenza Vaccine) Consumption Analysis by Major Regions

  • 5.3 Global Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

6 Product Commodity of Flu Vaccine (Influenza Vaccine) Market in Major Countries

  • 6.1 Top 5 Export Countries in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Flu Vaccine (Influenza Vaccine) Landscape Analysis

  • 7.1 North America Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

  • 7.2 North America Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

  • 7.3 North America Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Countries

    • 7.3.1 United States Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 7.3.2 Canada Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 7.3.3 Mexico Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

8 Europe Flu Vaccine (Influenza Vaccine) Landscape Analysis

  • 8.1 Europe Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

  • 8.2 Europe Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

  • 8.3 Europe Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Countries

    • 8.3.1 Germany Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.2 UK Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.3 France Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.4 Italy Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.6 Spain Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.7 Belgium Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.8 Poland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.9 Russia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 8.3.10 Turkey Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

9 Asia Pacific Flu Vaccine (Influenza Vaccine) Landscape Analysis

  • 9.1 Asia Pacific Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

  • 9.2 Asia Pacific Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Countries

    • 9.3.1 China Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 9.3.2 Japan Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 9.3.4 India Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 9.3.6 South Korea Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

10 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 10.3.2 Brazil Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 10.3.3 Nigeria Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    • 10.3.4 South Africa Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate 

    • 10.3.5 Argentina Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 CSL

    • 11.1.1 CSL Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 GSK

    • 11.2.1 GSK Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Sanofi Pasteur

    • 11.3.1 Sanofi Pasteur Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Mylan

    • 11.4.1 Mylan Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 AstraZeneca

    • 11.5.1 AstraZeneca Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Pfizer

    • 11.6.1 Pfizer Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Johnson & Johnson

    • 11.7.1 Johnson & Johnson Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 107 Figures and 163 Tables)

  • Figure Product Picture

  • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines from 2014 to 2026

  • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines from 2014 to 2026

  • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines from 2014 to 2026

  • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Children (6 months to 3 years) from 2014 to 2026

  • Figure Global Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Adults and Children over 3 years from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Flu Vaccine (Influenza Vaccine) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Flu Vaccine (Influenza Vaccine) Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Flu Vaccine (Influenza Vaccine)

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Flu Vaccine (Influenza Vaccine) by Different Types from 2014 to 2026

  • Table Consumption Share of Flu Vaccine (Influenza Vaccine) by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Whole Virus Vaccines

  • Figure Market Size and Growth Rate of Split Virus Vaccines

  • Figure Market Size and Growth Rate of Subunit Vaccines

  • Figure Market Size and Growth Rate of Live Attenuated Virus Vaccines

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Flu Vaccine (Influenza Vaccine) by Different End-Users from 2014 to 2026

  • Table Consumption Share of Flu Vaccine (Influenza Vaccine) by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of For Children (6 months to 3 years)

  • Figure Market Size and Growth Rate of For Adults and Children over 3 years

  • Table Global Flu Vaccine (Influenza Vaccine) Production by Major Regions

  • Table Global Flu Vaccine (Influenza Vaccine) Production Share by Major Regions

  • Figure Global Flu Vaccine (Influenza Vaccine) Production Share by Major Regions in 2014

  • Figure Global Flu Vaccine (Influenza Vaccine) Production Share by Major Regions in 2018

  • Figure Global Flu Vaccine (Influenza Vaccine) Production Share by Major Regions in 2026

  • Table Global Flu Vaccine (Influenza Vaccine) Consumption by Major Regions

  • Table Global Flu Vaccine (Influenza Vaccine) Consumption Share by Major Regions

  • Figure Global Flu Vaccine (Influenza Vaccine) Consumption Share by Major Regions in 2014

  • Figure Global Flu Vaccine (Influenza Vaccine) Consumption Share by Major Regions in 2018

  • Figure Global Flu Vaccine (Influenza Vaccine) Consumption Share by Major Regions in 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

  • Table Europe Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Flu Vaccine (Influenza Vaccine) market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2014

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2018

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2014

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2018

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

  • Table North America Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2014

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2018

  • Figure North America Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2026

  • Figure United States Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2014

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2018

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2014

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2018

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

  • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2014

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2018

  • Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2026

  • Figure Germany Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure France Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2014

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2018

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2014

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2018

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2026

  • Figure China Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandFlu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure India Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries in 2026

  • Figure GCC Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of CSL

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

  • Figure Sales and Growth Rate Analysis of CSL

  • Figure Revenue and Market Share Analysis of CSL

  • Table Product and Service Introduction of CSL

  • Table Company Profile and Development Status of GSK

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

  • Figure Sales and Growth Rate Analysis of GSK

  • Figure Revenue and Market Share Analysis of GSK

  • Table Product and Service Introduction of GSK

  • Table Company Profile and Development Status of Sanofi Pasteur

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

  • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

  • Figure Revenue and Market Share Analysis of Sanofi Pasteur

  • Table Product and Service Introduction of Sanofi Pasteur

  • Table Company Profile and Development Status of Mylan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

  • Figure Sales and Growth Rate Analysis of Mylan

  • Figure Revenue and Market Share Analysis of Mylan

  • Table Product and Service Introduction of Mylan

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top